| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57c4705bc2cbc228afd692d86c4e27a4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
| filingDate |
2004-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2da8b4f66ee3948ab28a9ac95130662 |
| publicationDate |
2004-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004113338-A1 |
| titleOfInvention |
Novel imidazopyridine compound i with therapeutic effect |
| abstract |
The present invention relates to imidazo pyridine derivatives of the Formula I which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastric acid related diseases or gastrointestinal inflammatory diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101742328-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2509771-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8993589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102239167-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8669269-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007039464-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011004882-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010063876-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015063548-A |
| priorityDate |
2003-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |